We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
-9.23%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$105M
AUM Growth
-$17M
Cap. Flow
-$5.64M
Cap. Flow %
-5.37%
Top 10 Hldgs %
22.62%
Holding
208
New
36
Increased
43
Reduced
58
Closed
48

Top Buys

Rank Stock Value
1
JWN
Nordstrom
JWN
+$2.21M
2
WFC icon
Wells Fargo
WFC
+$1.31M
3
DIS icon
Walt Disney
DIS
+$822K
4
MS icon
Morgan Stanley
MS
+$733K
5
TNL icon
Travel + Leisure Co
TNL
+$730K

Sector Composition

Rank Sector Weight
1 Healthcare 21.68%
2 Industrials 15.5%
3 Financials 13.39%
4 Consumer Staples 13.19%
5 Consumer Discretionary 12.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHMT
76
DELISTED
Chemtura Corporation
CHMT
$504K 0.48%
17,600
+1,200
+7% +$32.8K
ABBV icon
77
AbbVie
ABBV
$463B
$496K 0.47%
9,108
+4,300
+89% +$280K
AVNS
78
DELISTED
Avanos Medical
AVNS
$492K 0.47%
17,307
+3,975
+30% +$139K
FSLR icon
79
First Solar
FSLR
$21.4B
$483K 0.46%
11,300
+2,900
+35% +$134K
LCI
80
DELISTED
Lannett Company, Inc.
LCI
$475K 0.45%
+2,860
New +$628K
PII icon
81
Polaris
PII
$3.32B
$473K 0.45%
+3,950
New +$536K
K
82
DELISTED
Kellanova
K
$471K 0.45%
7,532
-5,006
-40% -$312K
RVTY icon
83
Revvity
RVTY
$16.3B
$466K 0.44%
+10,150
New +$504K
GOOG icon
84
Alphabet (Google) Class C
GOOG
$4.19T
$465K 0.44%
15,300
-6,800
-31% -$209K
PRXL
85
DELISTED
Parexel International Corp
PRXL
$457K 0.43%
7,375
-700
-9% -$47.1K
CL icon
86
Colgate-Palmolive
CL
$69.7B
$454K 0.43%
+7,150
New +$467K
KO icon
87
Coca-Cola
KO
$380B
$450K 0.43%
11,223
FLR icon
88
Fluor
FLR
$7.2B
$441K 0.42%
10,404
+50
+0.5% +$2.35K
CNBKA
89
DELISTED
Century Bancorp Inc/Mass
CNBKA
$440K 0.42%
10,795
-100
-0.9% -$4.09K
TGT icon
90
Target
TGT
$70.3B
$425K 0.4%
+5,400
New +$431K
APD icon
91
Air Products & Chemicals
APD
$65B
$421K 0.4%
3,567
CSCO icon
92
Cisco
CSCO
$437B
$421K 0.4%
16,025
-16,671
-51% -$450K
GSK icon
93
GSK
GSK
$101B
$417K 0.4%
8,680
-10,187
-54% -$530K
PKG icon
94
Packaging Corp of America
PKG
$20.9B
$414K 0.39%
6,875
-2,275
-25% -$152K
GOOGL icon
95
Alphabet (Google) Class A
GOOGL
$4.24T
$412K 0.39%
+12,900
New +$415K
STJ
96
DELISTED
St Jude Medical
STJ
$405K 0.39%
+6,425
New +$459K
SBUX icon
97
Starbucks
SBUX
$112B
$404K 0.38%
7,100
-3,000
-30% -$168K
ELV icon
98
Elevance Health
ELV
$90.7B
$392K 0.37%
+2,800
New +$421K
EOG icon
99
EOG Resources
EOG
$77.5B
$389K 0.37%
5,345
-2,300
-30% -$179K
PCRX icon
100
Pacira BioSciences
PCRX
$968M
$389K 0.37%
9,460
-300
-3% -$18.4K

Similar funds

New England Research & Management's Q3 2015 Portfolio in Review

As of Q3 2015, New England Research & Management held 208 positions worth $105M, down 14% from $122M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

New England Research & Management withdrew a net $5.64M in Q3 2015, closing 48 positions and reducing 58 holdings. Its most notable exit was United Parcel Service, an estimated $1.54M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.

Against the trend, New England Research & Management opened a new position in Nordstrom worth $2.1M.

  • New England Research & Management's largest Q3 2015 buy was Nordstrom: 29,300 shares worth $2.1M.
  • New England Research & Management added most to Wells Fargo in Q3 2015, an estimated $1.31M increase.
  • New England Research & Management's biggest Q3 2015 reduction was Sysco, cutting an estimated $846K.
  • New England Research & Management fully exited United Parcel Service in Q3 2015, selling an estimated $1.54M.
  • New England Research & Management's ten largest holdings make up 23% of its $105M portfolio in Q3 2015.
  • New England Research & Management opened 36 new positions and closed 48 in Q3 2015.
  • New England Research & Management's portfolio value fell 14% quarter-over-quarter to $105M.

Based on New England Research & Management's 13F filing for Q3 2015, filed 6 Oct 2015.